Nautilus Biotechnology (NAUT) Revenue (2026)
Nautilus Biotechnology (NAUT) posted Revenue of $190000.0 for Q2 2026.
Nautilus Biotechnology (NAUT) Revenue (2026) Analysis & Trends
Nautilus Biotechnology has reported Revenue for 1 years, with the latest figure at $190000.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Nautilus Biotechnology | 120.79 Mn | 120.79 Mn | 175,000.00 | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 190,000.00 |